Brought to you byInfluencer AdvisoryYour wellness & health influencer agency
UCB ran dozens of micro-influencers, and a drug maker is legally obliged to catch and report any side effect any of them mentions.
The problem is documented by somebody with nothing to gain from the agency winning the work.
How we know
The entry title itself states the model: "UCB Pharmaceuticals / Syneos Health | Shine Forward Micro-Influencer Program". Adverse event reporting is a legal duty on pharmaceutical manufacturers, which is what makes a micro-influencer programme expensive to run.
| Who says so | FiercePharma's 2026 finalist list, and nothing else. No campaign detail, spend, market, dates or named executive exists anywhere. Read it |
|---|---|
| A second source | No second independent outlet was found reporting this brand and agency pairing. The finalist listing is the only source located. |
| What the agency was asked to do | Not published as a quoted brief. On record: the entry is named Shine Forward Micro-Influencer Program and was judged in the Influencer-Driven Campaign category at the 2026 Fierce Pharma Marketing Awards. |
| How that happened | The only evidence is a trade award finalist listing. No appointment story, pitch or roster detail is published. |
| How long it took | 2026 awards cycle. Campaign dates, appointment date and contract length not found. |
| Recorded as | UCB Pharmaceuticals (Shine Forward) |
Every other case where there were rules about what they could say →
← Every caseEvery case here carries the one link that proves it, and names who said it. Where that is the agency describing its own win, the card says so rather than hiding it. Cases where nobody ever documented a reason are not on this page at all. Brought to you by Influencer Advisory, your influencer marketing partner for supplement, health and beverage brands.